FDA reverses course and will review Moderna’s mRNA-based flu shot
- Posted on February 18, 2026
- By Washington Post
- 3 Views
FDA reverses course and will review Moderna’s mRNA-based flu shot
Moderna announced that the FDA agreed to review its application for a mRNA-based flu vaccine after it agreed to further studies. Federal officials did not immediately comment.
